sodium montelukast
PolandDrugs containing this active substance
-
The medicine is used in adults and adolescents over 15 years of age for the treatment of asthma and the prevention of exercise-induced symptoms. It may also relieve the symptoms of seasonal allergic rhinitis.
Form: tablets, film-coated
Active substance Dosage sodium montelukast 10.4 mg ATC: R03DC03
Manufacturer: Polpharma Pharmaceutical Works S.A.
-
It is used as an adjunct in the treatment of mild to moderate chronic asthma in children aged 2 to 5 years. It also helps to prevent airway constriction primarily induced by physical exertion in children over 2 years of age.
Form: tablets, chewable
Active substance Dosage sodium montelukast 4 mg ATC: R03DC03
Manufacturer: Polfarmex S.A.
-
The medicine helps to relieve the symptoms of chronic asthma (mild or moderate) in children aged 6 to 14 years and prevents airway constriction mainly induced by physical exertion.
Form: tablets, chewable
Active substance Dosage sodium montelukast 5 mg ATC: R03DC03
Manufacturer: Polfarmex S.A.
-
The medicine is used for the treatment of asthma in children aged 6 to 14 years (to prevent daytime and nighttime symptoms and to prevent airway narrowing during physical exertion), as well as for the treatment of seasonal allergic rhinitis.
Form: tablets, chewable
Active substance Dosage sodium montelukast 5.2 mg ATC: R03DC03
Manufacturer: Adamed Pharma S.A.
-
The medicine is used to relieve asthma symptoms, prevent asthma exacerbations (including those induced by physical exertion), and to treat the symptoms of seasonal allergic rhinitis (hay fever).
Form: tablets, film-coated
Active substance Dosage sodium montelukast 10.4 mg ATC: R03DC03
Manufacturer: Adamed Pharma S.A.
-
The medicine is used for the treatment of asthma in children (aged 2 to 5 years) and to prevent exercise-induced bronchoconstriction in individuals over 2 years of age.
Form: tablets, chewable
Active substance Dosage sodium montelukast 4.16 mg ATC: R03DC03
Manufacturer: Adamed Pharma S.A.
-
Monkasta is used for the treatment of children and adolescents aged 6 to 14 years to prevent asthma symptoms during the day and at night. It also helps to prevent exercise-induced bronchoconstriction.
Form: tablets, chewable
Active substance Dosage sodium montelukast 5.2 mg ATC: R03DC03
Manufacturer: Krka, d.d., Novo mesto Krka Polska Sp. z o.o. TAD Pharma GmbH
-
The medicine is used in children aged 2 to 5 years to prevent asthma symptoms during the day and at night. It may also help prevent exercise-induced bronchoconstriction.
Form: tablets, chewable
Active substance Dosage sodium montelukast 4.16 mg ATC: R03DC03
Manufacturer: Krka, d.d., Novo mesto Krka Polska Sp. z o.o. TAD Pharma GmbH
-
This medicine is used to treat asthma in children to prevent symptoms during the day and at night. It also helps to prevent exercise-induced bronchoconstriction in individuals over 2 years of age.
Form: tablets, chewable
Active substance Dosage sodium montelukast 4.15 mg ATC: R03DC03
Manufacturer: APL Swift Services (Malta) Ltd.
-
The medicine is used for the treatment of asthma and the prevention of its symptoms during the day and night in children aged 2 to 5 years. It also helps to prevent exercise-induced bronchoconstriction in children aged 2 years and older.
Form: tablets, chewable
Active substance Dosage sodium montelukast 4.16 mg ATC: R03DC03
Manufacturer: Bluefish Pharmaceuticals AB
-
The medicine is used for the treatment of asthma and to prevent its symptoms during the day and night. It also helps to prevent exercise-induced bronchoconstriction.
Form: tablets, chewable
Active substance Dosage sodium montelukast 5.2 mg ATC: R03DC03
Manufacturer: Bluefish Pharmaceuticals AB
-
The medicine is used to prevent the occurrence of asthma symptoms during the day and at night and helps to control this disease. It also helps to prevent exercise-induced bronchoconstriction.
Form: tablets, chewable
Active substance Dosage sodium montelukast 5 mg ATC: R03DC03
Manufacturer: Pharmaceutical Enterprise LEK-AM Ltd.
-
The medicine is used for the treatment of bronchial asthma and to prevent its symptoms during the day and at night. It also helps to prevent exercise-induced bronchoconstriction and relieves the symptoms of seasonal allergies (hay fever).
Form: tablets, film-coated
Active substance Dosage sodium montelukast 10.4 mg ATC: R03DC03
Manufacturer: Lek Pharmaceuticals d.d.
-
The medicine is used for the treatment of asthma in children and to prevent its symptoms during the day and at night. It also helps to prevent exercise-induced bronchoconstriction.
Form: tablets, chewable
Active substance Dosage sodium montelukast 4.16 mg ATC: R03DC03
Manufacturer: Lek Pharmaceuticals d.d.
-
The medicine is used for the treatment of asthma in children and to prevent its symptoms during the day and at night. It also helps to prevent exercise-induced bronchoconstriction.
Form: tablets, chewable
Active substance Dosage sodium montelukast 5.2 mg ATC: R03DC03
Manufacturer: Lek Pharmaceuticals d.d.
-
The medicine is used for the treatment of asthma in children and to prevent its symptoms during the day and at night. It also helps to prevent exercise-induced bronchoconstriction in children over 2 years of age.
Form: granules
Active substance Dosage sodium montelukast 4.15 mg ATC: R03DC03
Manufacturer: Lek Pharmaceuticals d.d.
-
The medicine is used to prevent asthma symptoms during the day and at night in children aged 2 to 5 years. It also helps to prevent exercise-induced bronchoconstriction.
Form: tablets, chewable
Active substance Dosage sodium montelukast 4.16 mg ATC: R03DC03
Manufacturer: Orion Corporation, Orion Pharma
-
The medicine is used to prevent asthma symptoms during the day and at night and helps to prevent exercise-induced bronchoconstriction. It is intended for children aged 6 to 14 years.
Form: tablets, chewable
Active substance Dosage sodium montelukast 5.2 mg ATC: R03DC03
Manufacturer: Orion Corporation, Orion Pharma
-
The medicine is used to prevent asthma symptoms during the day and at night, and to prevent exercise-induced bronchoconstriction. It also helps to relieve symptoms of seasonal allergies (hay fever).
Form: tablets
Active substance Dosage sodium montelukast 10.4 mg ATC: R03DC03
Manufacturer: Orion Corporation Orion Pharma
-
The medicine is used to relieve asthma symptoms, prevent symptoms during the day and at night, and prevent exercise-induced bronchoconstriction. It also helps relieve the symptoms of seasonal allergic rhinitis (hay fever).
Form: tablets, film-coated
Active substance Dosage sodium montelukast 10.4 mg ATC: R03DC03
Manufacturer: HBM Pharma s.r.o. Saneca Pharmaceuticals a.s.
-
The medicine is used for the treatment of asthma in children aged 2 to 5 years to prevent symptoms during the day and at night. It also helps to prevent exercise-induced bronchoconstriction.
Form: tablets, chewable
Active substance Dosage sodium montelukast 4.16 mg ATC: R03DC03
Manufacturer: HBM Pharma s.r.o. Saneca Pharmaceuticals a.s.
-
The medicine is used for the treatment of asthma in children aged 6 to 14 years to prevent symptoms during the day and at night. It also helps to prevent exercise-induced bronchoconstriction.
Form: tablets, chewable
Active substance Dosage sodium montelukast 2.2 mg ATC: R03DC03
Manufacturer: HBM Pharma s.r.o. Saneca Pharmaceuticals a.s.
-
The medicine is used to treat asthma in children to prevent symptoms during the day and at night. It also helps to prevent exercise-induced bronchoconstriction in patients over 2 years of age.
Form: tablets, chewable
Active substance Dosage sodium montelukast 4 mg ATC: R03DC03
Manufacturer: Sun Pharmaceuticals Industries Europe B.V., Terapia S.A.
-
The medicine is used for the treatment of asthma in children aged 6 to 14 years. It helps prevent asthma symptoms during the day and at night and prevents exercise-induced bronchoconstriction.
Form: tablets, chewable
Active substance Dosage sodium montelukast 5 mg ATC: R03DC03
Manufacturer: Sun Pharmaceuticals Industries Europe B.V., Terapia S.A.